Category: 4. Health

University of Virginia School of Medicine scientists have been investigating the possibility that Alzheimer’s is caused, at least in part, by the immune system’s wayward attempts to fix DNA damage in the brain. Their research reveals that an immune molecule called STING drives the formation of the harmful…

The collaborative study led by researchers at RMIT University in Australia is the first reported use of antibacterial coatings made from resilin-mimetic proteins to fully block bacteria from attaching to a surface.

Study lead author Professor Namita Roy Choudhury said the finding is a critical step towards their…

Set to launch this month, a recently approved blood test to detect biomarkers for Alzheimer’s disease could bring diagnosis into everyday clinical practice. In turn, this may support earlier intervention approaches that may help patients, their families and caregivers. The diagnostic, called a Lumipulse G Plasma Ratio test, is the first of its kind to get marketing clearance from the Food and Drug Administration. Until now,…

For the first time, we are witnessing therapies that can fundamentally alter the course of inherited disease lifelong. The most recent breakthrough describes treating inherited disease in infants. In a case in Nature Medicine, a…

The recent announcement that Teva Pharmaceuticals will lay off roughly 2,400 employees–approximately 8% of its global workforce–is a significant development in a sector already under strain. This move aims to save $700 million by 2027 as Teva attempts to rebalance its role as both a generics manufacturer…

Given the Trump administration’s systematic attempts to medically and legally disenfranchise trans people, and its abrupt termination of grants focused on LGBTQ+ health, we can’t say that the notice of termination we received regarding our federally funded research on transgender and nonbinary people’s health was unexpected.

As researchers who study the experiences of trans and nonbinary people, we have collectively dedicated nearly 50 years of our scientific careers to…

A new survey report from the International Foundation of Employee Benefit Plans shows continued reluctance by United States employers to cover glucagon-like peptide-1 drugs for weight loss. Going forward, however, lower net costs may induce better coverage by employers. Makers of GLP-1s for obesity are offering an array of discounts, some to…

At the May annual meeting of the World Health Organization’s members in Geneva, Switzerland, officials and delegates spoke of the potential disruption that could be caused by the organization’s…

In a major policy shift last month, Food and Drug Administration officials proposed requiring new clinical trial research with respect to the effectiveness of COVID-19 vaccines in healthy people under 65, including pregnant women, before issuing an updated…

RFK Jr. and the HHS will no longer recommend annual COVID-19 vaccines for healthy pregnant women and young adults, according to a video announcement posted on X May 27 by Secretary of Health and Human Services Robert F. Kennedy Jr. A few days later,…